We use cookies to ensure that we give you the best experience on our website Learn more

Home

Saved research

Submission

Trial-level comparisons of iGlarLixi versus IDegLira in the LixiLan and DUAL clinical development programmes

Submitted

18 Views
0 Downloads
0 Saves

Presentation

thumbnail

Abstract

No abstract is available for this submission.

Datasets

No datasets are available for this submission.

Keywords

No keywords are available for this submission

License

No license information is available for this submission.

Company

Legal

Follow us

© Copyright 2019 Morressier GmbH. All rights reserved.

© Copyright 2019 Morressier GmbH.
All rights reserved.